What are the optimal total cholesterol-to-HDL and LDL-to-HDL ratio ranges?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Optimal Cholesterol Ratios for Cardiovascular Risk Assessment

The total cholesterol-to-HDL ratio (TC/HDL) is the superior lipid metric for risk stratification, with optimal values below 3.5, borderline risk at 3.5–5.0, and elevated risk above 5.0; specifically, ratios above 5.6 in women and 6.4 in men identify significantly increased cardiovascular risk. 1, 2

Primary Ratio: Total Cholesterol/HDL

The TC/HDL ratio consistently outperforms isolated LDL-C measurements and the LDL/HDL ratio in predicting atherosclerotic cardiovascular disease (ASCVD) events 1, 2:

  • Women: TC/HDL ratio ≥5.6 identifies 0–15% more high-risk individuals with 25–45% greater ASCVD risk compared to LDL-C thresholds alone 1
  • Men: TC/HDL ratio ≥6.4 identifies 69–95% more high-risk individuals with 2–14% greater risk than LDL-C alone 1
  • Eight-year likelihood ratios for coronary heart disease range from 0.32 (TC/HDL <3) to 3.11 (TC/HDL ≥9) in men and 0.59 to 2.98 in women 1
  • TC/HDL ratio is the strongest predictor of subclinical atherosclerosis measured by intima-media thickness (odds ratio 1.21 per unit increase) 2

Secondary Ratio: LDL/HDL

The LDL/HDL ratio provides additional information but has important limitations 3, 4:

  • Critical caveat: LDL/HDL ratio systematically underestimates risk in patients with elevated triglycerides (>168 mg/dL), metabolic syndrome, or insulin resistance 3
  • For any given LDL/HDL ratio, patients with high triglycerides have substantially higher TC/HDL ratios and worse metabolic profiles 3
  • The interaction between LDL and HDL is complex and non-linear; benefits of lowering LDL are greatest when HDL is low, and benefits of raising HDL are strongest when LDL is high 4
  • Using LDL/HDL ratio alone fails to capture this interaction and may underestimate treatment benefits 4

Clinical Discordance and Risk Implications

Discordance between TC/HDL ratio and LDL-C occurs frequently and carries prognostic significance 5:

  • Among individuals with LDL-C below the median, 26% have discordantly elevated TC/HDL ratio (≥median) 5
  • These discordant patients have 24% higher risk of incident ASCVD (HR 1.24,95% CI 1.09–1.41) compared to those with concordantly low values 5
  • In diabetes: Discordance is even more prevalent (48% with low LDL-C but high TC/HDL ratio), making TC/HDL ratio particularly valuable in this population 5
  • When non-HDL-C is below the median but TC/HDL ratio is elevated, ASCVD risk increases by 29% (HR 1.29,95% CI 1.13–1.46) 5

Guideline Context and Treatment Priorities

Current guidelines prioritize absolute LDL-C targets over ratio-based goals, but ratios remain valuable for risk stratification 6, 7:

  • The 2018 AHA/ACC guideline emphasizes LDL-C as the primary therapeutic target, with optimal levels around 100 mg/dL (2.6 mmol/L) in the general population and lower in high-risk patients 6
  • No specific HDL target is defined in current guidelines; while HDL >40 mg/dL is desirable, evidence does not support treating to a numeric HDL goal 7
  • Treatment hierarchy: (1) achieve LDL-C goal first, then (2) address low HDL as a secondary target 7
  • LDL-C goals: <100 mg/dL for high-risk, <70 mg/dL for very high-risk patients 7

Practical Application Algorithm

Use TC/HDL ratio for initial risk stratification, then manage based on absolute LDL-C targets:

  1. Calculate TC/HDL ratio from standard lipid panel (no fasting required for ratio calculation) 1, 2
  2. Risk stratification:
    • TC/HDL <3.5: Low risk
    • TC/HDL 3.5–5.0: Borderline risk
    • TC/HDL 5.0–6.4: Moderate-high risk (men); 5.0–5.6 (women)
    • TC/HDL >6.4 (men) or >5.6 (women): High risk 1, 2
  3. Check for discordance: If LDL-C appears reassuring but TC/HDL ratio is elevated, the patient carries higher risk than LDL-C alone suggests—especially with diabetes, metabolic syndrome, or triglycerides >150 mg/dL 3, 5
  4. Treat to LDL-C targets using statins as first-line therapy, with goals determined by overall ASCVD risk 6, 7
  5. Address low HDL through lifestyle (weight loss, exercise, smoking cessation) rather than pharmacologic HDL-raising in most patients 7

Common Pitfalls

  • Avoid relying solely on LDL/HDL ratio in patients with hypertriglyceridemia or metabolic syndrome, as it underestimates risk 3
  • Do not ignore elevated TC/HDL ratio even when LDL-C meets guideline targets; discordance identifies residual risk requiring intensified lifestyle modification or consideration of additional therapy 5
  • Recognize that ratio-based risk assessment complements but does not replace absolute LDL-C targets for treatment decisions 6, 7

References

7
Guideline

Management of Low HDL Cholesterol in Young Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the appropriate management for a patient with triglycerides 178 mg/dL, total cholesterol 213 mg/dL, LDL‑cholesterol 117 mg/dL, and HDL‑cholesterol 60 mg/dL?
What is the appropriate management for a 61-year-old woman with total cholesterol 209 mg/dL, triglycerides 158 mg/dL, HDL cholesterol 57 mg/dL, VLDL cholesterol 28 mg/dL, and LDL cholesterol 124 mg/dL?
What is the appropriate treatment plan for a patient with total cholesterol 226 mg/dL, triglycerides 153 mg/dL, and LDL cholesterol 150 mg/dL?
My total cholesterol is 248 mg/dL and LDL cholesterol is 156 mg/dL; what should I do?
What is the recommended management for a patient with a total cholesterol of 218 mg/dL?
What is the mechanism by which pickle juice stops hiccups?
Does postoperative scrotal fluid following inguinal hernia repair indicate a hydrocele?
Is it safe to add venlafaxine to a patient who is already prescribed sumatriptan (Imitrex) for acute migraine attacks and is taking buspirone and bupropion for depression?
What are the different types of interstitial lung disease (ILD)?
How should I adjust the risperidone dosing for a patient who is drowsy on 2 mg in the morning and 4 mg at night to minimize sedation?
What is the recommended prophylaxis for Plasmodium falciparum malaria?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.